DoW Bone Marrow Failure, Resource Development Award
About
Summary: The fiscal year 2026 (FY26) Bone Marrow Failure Research Program (BMFRP) Resource Development Award (RDA) supports the development of a multiomic atlas generated from well-annotated human bone marrow failure (BMF) samples, with omic data derived from marrow specimens. The resulting dataset should serve as an open-access, durable resource for the BMF research and clinical communities and is expected to facilitate key discoveries that advance the understanding of BMF diseases. Distinctive Features: The application must include a robust Data Resource Sharing Plan that describes the means and timeline by which the fully developed resource will be made available to the scientific and clinical community.
The DoW Bone Marrow Failure Resource Development Award supports researchers and institutions committed to advancing bone marrow failure (BMF) research through the creation of a comprehensive multiomic atlas. This grant funds the development of well-annotated human bone marrow failure samples with omic data derived from marrow specimens, resulting in an open-access resource for the research and clinical communities. Researchers, medical institutions, and organizations focused on hematology and bone marrow disorders should apply if they have the capacity to generate high-quality multiomic datasets and establish robust data sharing infrastructure. This award is ideal for teams that can contribute significantly to understanding BMF diseases while committing to making their findings and resources publicly available. By funding resource development rather than traditional research, this program addresses a critical gap in accessible, standardized datasets that can accelerate discoveries across the BMF field. Organizations with expertise in bone marrow analysis, multiomic profiling, and data management are particularly well-positioned to leverage this opportunity.
Funding Facts
● Applications openDeadline
November 4, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2026-11-04
Grant Type
federal
Application Cycle
Annual
Best For
Research institutions, academic medical centers, and organizations specializing in bone marrow failure research and multiomic analysis
Frequently Asked Questions
Who is eligible for DoW Bone Marrow Failure, Resource Development Award?
Specific eligibility criteria are not provided in the available information. Typically, Department of Defense grants support institutions and researchers capable of conducting federally-funded research. For detailed eligibility requirements, including institutional type, researcher credentials, and other qualifications, visit the official Department of Defense Bone Marrow Failure Research Program website or the grants.gov listing.
How much funding does DoW Bone Marrow Failure, Resource Development Award provide?
Funding amounts are not specified in the available information. Award amounts may vary by application cycle and project scope. Prospective applicants should consult the official Department of Defense grant announcement and grants.gov for current funding levels and budget guidelines.
How do I apply for DoW Bone Marrow Failure, Resource Development Award?
Applications are typically submitted through grants.gov or the Department of Defense's official grants portal. The deadline for FY2026 applications is November 4, 2026. Applicants must prepare a comprehensive application including a robust Data Resource Sharing Plan that outlines how the developed resource will be made available to the scientific and clinical community. Visit the official Department of Defense Bone Marrow Failure Research Program website for specific submission instructions, required documentation, and application guidelines.
What can DoW Bone Marrow Failure, Resource Development Award funding be used for?
Funding supports the development of a multiomic atlas generated from well-annotated human bone marrow failure samples, with omic data derived from marrow specimens. The resulting dataset must serve as an open-access, durable resource for the BMF research and clinical communities. A critical component is the development of a robust Data Resource Sharing Plan describing the means and timeline for making the resource available to researchers and clinicians.
Last updated: July 5, 2026